Globe Life named TD Cowen top pick, shares trade near 52-week high
23.06.2026 - 19:55:08 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 19:54.
Globe Life (US37959E1029) draws renewed analyst attention on Tuesday. TD Cowen lifted its price target to 215 dollars and called the NYSE-listed life insurer its top pick in U.S. life insurance, according to an Investing.com report.
TD Cowen lifts target and stance
TD Cowen raised its Globe Life price target from 199 to 215 dollars while reiterating a Buy rating, highlighting a strong fundamental outlook with expected low double-digit earnings per share growth. The brokerage also cited the company’s business model as among the most attractive in the life insurance sector in the United States.
The analyst note points to a current price-to-earnings ratio of roughly 11.9 and a PEG ratio of about 0.65 for Globe Life, indicating valuation that TD Cowen sees as appealing relative to projected growth. Despite a marked share-price advance over the past year, the firm argues that the stock still trades below its historical valuation averages.
Momentum, valuation and targets from peers
Globe Life shares have delivered around a 42 percent return over the past twelve months and recently traded close to a 52-week high near 175.6 dollars on the New York Stock Exchange. MarketBeat separately reported that the shares reached an intraday high of 175.63 dollars on Tuesday before last trading near 172.07 dollars, with roughly 895,000 shares changing hands.
Other research houses have adjusted their models as well. Raymond James lifted its Globe Life price target to 208 dollars from 188 dollars, citing strong cash flow generation, while BMO Capital increased its target to 150 dollars from 148 dollars, noting a 4 percent rise in the midpoint of excess cash flow guidance to 675 million dollars. Truist Securities raised its target to 185 dollars from 180 dollars, based on an updated 2026 EPS estimate of 15.60 dollars.
All news and analysis on the Globe Life shares
From analyst revisions to earnings updates, the Globe Life section on ad-hoc-news.de bundles price data, newsflow and background material on the NYSE-listed insurer.
What the company sells
Globe Life generates most of its revenue from life and supplemental health insurance policies for middle-income households in the United States, sold primarily through exclusive agents and direct-to-consumer channels. The company also offers annuity products and other financial protection solutions geared toward long-duration customer relationships.
Where the stock trades today
The Globe Life shares (US37959E1029) last traded on the NYSE on 2026-06-23 at about 172.07 dollars, after touching an intraday high of 175.63 dollars earlier in the session.
Key data on the Globe Life shares
- Company: Globe Life Inc.
- ISIN: US37959E1029
- WKN: A2PR5A
- Ticker: GL
- Trading venue: NYSE
- Price (as of 2026-06-23, 19:30): 172.07 USD
- Market cap: 16.8 billion USD (as of 2026-06-23)
- Sector / industry: Financials / Life & Health Insurance
- Index membership: S&P 500
- Next earnings date: 2026-07-22
Disclosure: This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any security. All figures and estimates are based on publicly available sources cited in the text and may change over time.
